120 related articles for article (PubMed ID: 1963768)
1. IP66 (1[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxy-phenyl)piperazine) enhances beta-adrenoceptor-induced vasodilatation in rat mesenteric vascular bed.
Perretti F; Nediani C; Manzini S
Arch Int Pharmacodyn Ther; 1990; 306():87-99. PubMed ID: 1963768
[TBL] [Abstract][Full Text] [Related]
2. The involvement of ATP-sensitive potassium channels in beta 2-adrenoceptor agonist-induced vasodilatation on rat diaphragmatic microcirculation.
Chang HY
Br J Pharmacol; 1997 Jul; 121(5):1024-30. PubMed ID: 9222563
[TBL] [Abstract][Full Text] [Related]
3. Involvement of calcitonin gene-related peptide (CGRP) receptors in insulin-induced vasodilatation in mesenteric resistance blood vessels of rats.
Mimaki Y; Kawasaki H; Okazaki M; Nakatsuma A; Araki H; Gomita Y
Br J Pharmacol; 1998 Apr; 123(8):1684-90. PubMed ID: 9605576
[TBL] [Abstract][Full Text] [Related]
4. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
5. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
6. alpha(1D)-adrenoceptors cause endothelium-dependent vasodilatation in the rat mesenteric vascular bed.
Filippi S; Parenti A; Donnini S; Granger HJ; Fazzini A; Ledda F
J Pharmacol Exp Ther; 2001 Mar; 296(3):869-75. PubMed ID: 11181918
[TBL] [Abstract][Full Text] [Related]
7. Vasodilator responses to dopamine in rat perfused mesentery are age-dependent.
Wanstall JC; O'Donnell SR
Br J Pharmacol; 1989 Sep; 98(1):302-8. PubMed ID: 2804550
[TBL] [Abstract][Full Text] [Related]
8. Failure of propranolol to inhibit the epinephrine-induced enhancement of responses to sympathetic nerve stimulation in the rat mesenteric vascular bed.
Falckh PH; de la Lande IS; Stitzel RE; Mano M; Head RJ
J Pharmacol Exp Ther; 1990 May; 253(2):432-6. PubMed ID: 2338640
[TBL] [Abstract][Full Text] [Related]
9. Resolution and pharmacological properties of the enantiomers of the potent alpha-adrenoceptor antagonist 1-[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxy-phenyl)piperazine.
Bonacchi G; Agostini O; Fedi M; Bacciarelli C; Boni P; Castellucci A; Perretti F; Manzini S
Arzneimittelforschung; 1988 May; 38(5):650-4. PubMed ID: 2901262
[TBL] [Abstract][Full Text] [Related]
10. Effect of clenbuterol on non-endothelial nitric oxide release in rat mesenteric arteries and the involvement of beta-adrenoceptors.
Marín J; Balfagón G
Br J Pharmacol; 1998 Jun; 124(3):473-8. PubMed ID: 9647470
[TBL] [Abstract][Full Text] [Related]
11. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat.
Kerns WD; Arena E; Macia RA; Bugelski PJ; Matthews WD; Morgan DG
Toxicol Pathol; 1989; 17(1 Pt 2):203-13. PubMed ID: 2568682
[TBL] [Abstract][Full Text] [Related]
13. The role of adrenergic receptors in Ni2+-induced coronary vasoconstriction.
Rubányi G; Hajdú K; Pataki T; Bakos M
Acta Physiol Acad Sci Hung; 1982; 59(2):161-7. PubMed ID: 6297240
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.
Nichols AJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):455-63. PubMed ID: 3039117
[TBL] [Abstract][Full Text] [Related]
15. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat.
Kerns WD; Arena E; Morgan DG
Am J Pathol; 1989 Aug; 135(2):339-49. PubMed ID: 2571297
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects and interaction with adrenoceptors of urapidil.
van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ
Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
[TBL] [Abstract][Full Text] [Related]
17. [Do renal vascular D2 receptors exist?].
Barthelmebs M; Krieger JP; Grima M; Imbs JL
Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1211-3. PubMed ID: 1953269
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenoceptor-mediated inhibition of alpha 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig.
Haynes JM; Hill SJ
Br J Pharmacol; 1997 Nov; 122(6):1067-74. PubMed ID: 9401771
[TBL] [Abstract][Full Text] [Related]
19. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by urotensin I, a selective mesenteric vasodilator peptide.
Bolt GR; Itoh H; Lederis K; MacCannell KL
J Pharmacol Exp Ther; 1987 Jul; 242(1):284-91. PubMed ID: 3039111
[TBL] [Abstract][Full Text] [Related]
20. Anatomical localization of the binding and functional characterization of responses to dopexamine hydrochloride in the rat mesenteric vasculature.
Amenta F; Ricci A; Napoleone P; Vyas SJ; Lokhandwala MF
Pharmacology; 1991; 42(4):211-22. PubMed ID: 1677201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
